Brussels - Delayed Quote EUR
Hyloris Pharmaceuticals SA (HYL.BR)
6.30
-0.05
(-0.74%)
At close: April 25 at 5:19:10 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12,808
-12,808
-13,020
-11,250
-4,570
Investing Cash Flow
9,889
9,889
-11,373
-3,075
-633
Financing Cash Flow
-131
-131
7,838
-62
69,397
End Cash Position
30,406
30,406
33,457
50,012
64,399
Capital Expenditure
-750
-750
-739
-1,061
-623
Issuance of Capital Stock
--
--
17,169
--
59,254
Issuance of Debt
51
51
--
--
18,244
Repayment of Debt
--
--
-7,376
-62
-8,101
Free Cash Flow
-13,558
-13,558
-13,759
-12,311
-5,193
12/31/2020 - 6/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDD.F Innate Pharma S.A.
1.7460
+0.58%
TUB.BR Financière de Tubize SA
118.40
+1.72%
BIOS.BR BioSenic S.A.
0.0013
0.00%
CYAD.BR Celyad Oncology SA
0.4810
+0.21%
ARGX.BR argenx SE
535.80
+0.79%
ONWD.BR Onward Medical N.V.
4.0150
-0.12%
GLPG.AS Galapagos NV
23.40
+1.83%
UCB.BR UCB SA
149.70
+2.57%
INVA Innoviva, Inc.
18.24
-0.76%
ITOS iTeos Therapeutics, Inc.
7.35
-1.47%